MEDIA ALERT: BioSymetrics to Demonstrate Usage of Artificial Intelligence for Healthcare and Biomedical R&D Innovation at Collision 2019
TORONTO – (May 21, 2019) – Biomedical artificial intelligence (AI) company BioSymetrics will be attending Collision 2019, which is being held May 20-23 at the Entercare Centre in Toronto. BioSymetrics is pioneering proprietary data science and machine learning software in order to best optimize medical discovery and life sciences productivity.The company’s Chief Scientific Officer, Gabe Musso, will be available for meetings at Collision during the HealthConf track on Thursday, May 23, at BioSymetrics’ booth (Booth #B101) and can discuss how BioSymetrics’ inaugural product, the Augusta™ software platform, provides a holistic solution to some of the current industry challenges, including the utilization of good data without bias to feed machine learning models, as well as solving the ability to interrogate multiple models. BioSymetrics simplifies biomedical data science projects by reducing the time spent on data pre-processing, thus ultimately helping to build more effective predictive models that enable solutions to reach the market more quickly.NOTE: Booth #B101 will be located in a different area on Thursday; please ask for directions at the information desk.
Media & Analyst Briefings
To schedule a briefing with BioSymetrics at Collision, please contact BioSymetrics’ PR team at 774-551-6679 or kgrill@elevatecom.com.About BioSymetricsFor additional information, visit https://www.biosymetrics.com. Media Contacts: Korie Grill, Account ExecutiveElevate Communicationskgrill@elevatecom.com